Mark Iwicki

Board Chair at Akero Therapeutics - South San Francisco, CA, US

Mark Iwicki's Colleagues at Akero Therapeutics
Timothy Rolph

Chief Scientific Officer

Contact Timothy Rolph

John CEP

Vice President Finance and Controller

Contact John CEP

Kitty Yale

EVP and Chief Development Officer

Contact Kitty Yale

Brittany De Temple

director of clinical operations and program management

Contact Brittany De Temple

View All Mark Iwicki's Colleagues
Mark Iwicki's Contact Details
HQ
650-487-6488
Location
Greater Boston
Company
Akero Therapeutics
Mark Iwicki's Company Details
Akero Therapeutics logo, Akero Therapeutics contact details

Akero Therapeutics

South San Francisco, CA, US • 20 - 49 Employees
BioTech/Drugs

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being evaluated in a Phase 2b clinical trial as a potential treatment for NASH. Akero is headquartered in South San Francisco.

N/A
Details about Akero Therapeutics
Frequently Asked Questions about Mark Iwicki
Mark Iwicki currently works for Akero Therapeutics.
Mark Iwicki's role at Akero Therapeutics is Board Chair.
Mark Iwicki's email address is ***@akerotx.com. To view Mark Iwicki's full email address, please signup to ConnectPlex.
Mark Iwicki works in the BioTech/Drugs industry.
Mark Iwicki's colleagues at Akero Therapeutics are Thomas Quinn, Timothy Rolph, Louben Dorval, John CEP, Yasmine CPA, Kitty Yale, Brittany De Temple and others.
Mark Iwicki's phone number is 650-487-6488
See more information about Mark Iwicki